Interestingly, a few breakpoints were the same as those reported in the mixed lineage leukaemia (MLL)-AF9 fusion gene in an acute lymphoblastic leukaemia (ALL) patient. This evidence concerns the gene MLLT3 and acute lymphoblastic leukemia.